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Abstract: 
 
Background: Methylsulfonylmethane (MSM) is a dietary supplement to 
support healthy body. It is considered to be one of the least toxic 
substances in biology. Considering preventive effects of this substance on 
tumor onset and its low toxicity to healthy body we investigated in vitro 
cytotoxic effects of methylsulfonylmethane on cancer cell lines. Methods: 
AGS, HepG2 and KYSE-30 cancer cell lines were treated by MSM by 
initial concentration of 50 mg/ml with ¼ serial dilutions and incubated for 
24, 48 and 72 hours. Cytotoxicity was examined through MTT, neutral red 
uptake and protein measurement assays. EB/AO staining was used for 
apoptotic cell detection. A DAPI staining method was used to analysis cell 
cycle by flow cytometry. Results: IC50 of the MSM  on AGS, HepG2 and 
KYSE-30 cell lines were 28.04, 21.87 and 27.98 mg/ml after 72 hours 
respectively. The EB/AO staining showed an increase in apoptotic cells 
after MSM treatment. The flow cytometry cell cycle analysis showed a 
significant increase in cell density at G2/M phase. Conclusion: MSM had 
cytotoxic effect on cancer cell lines but HepG2 cell line was more 
susceptible. This study provides the evidence that MSM may induce 
cytotoxic effect on cancer cell lines by apoptosis and it could be of value in 
realm of chemotherapy. 
 
Key Words: Methylsulfonylmethane, MSM, Cancer cell lines, 
Cytotoxicity, Apoptosis, Adjuvant 
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µl Micro-liter 
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cm Centimeter 
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FDA Food and Drug Administration 
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HBV Hepatitis B Virus 
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kg Kilogram 
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min Minute 
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mol wt Molecular Weight 
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1: Introduction 
 
 
1.1 Cancer: 
 
Cancer causes about one-fifth of the deaths each year. About 100-350 of 
100,000 people scarify by cancer in a year. Cancer is due to failure of the 
mechanisms that usually control the growth and proliferation of cells. 
Throughout adult life and during normal development, genetic control 
systems regulate the balance between cell birth and death in response to 
various signals. Cell birth and death rates determine adult body size. The 
cells in many adult tissues normally do not proliferate except during 
healing processes. Such stable cells (e.g., hepatocytes, gastric and intestinal 
epithelial cells, and white blood cells) can remain functional for long 
periods or even for the entire lifetime of an organism. Cancer occurs when 
the mechanisms that maintain these normal growth rates malfunction to 
cause excess cell division. The failure of cellular regulation that give rise to 
most or all cases of cancer are due to genetic damage that is often 
accompanied by influences of tumor-promoting chemicals, hormones and 
sometimes viruses [1] ( Figure 1-1). 
 
